−1.78 USD
−5.09 M USD
0.00 USD
1.80 M
About Lixte Biotechnology Holdings, Inc.
Sector
Industry
CEO
Bastiaan van der Baan
Website
Headquarters
Pasadena
Founded
2005
FIGI
BBG000TC15T7
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets. The company was founded by John S. Kovach and Robert B. Royds on May 24, 2005 and is headquartered in Pasadena, CA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of LIXT is 1.63 USD — it has increased by 7.24% in the past 24 hours. Watch Lixte Biotechnology Holdings, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lixte Biotechnology Holdings, Inc. stocks are traded under the ticker LIXT.
LIXT stock has risen by 2.52% compared to the previous week, the month change is a −16.84% fall, over the last year Lixte Biotechnology Holdings, Inc. has showed a −43.22% decrease.
LIXT reached its all-time high on Aug 22, 2018 with the price of 110.44 USD, and its all-time low was 1.31 USD and was reached on Oct 28, 2024. View more price dynamics on LIXT chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
LIXT stock is 17.20% volatile and has beta coefficient of −1.52. Track Lixte Biotechnology Holdings, Inc. stock price on the chart and check out the list of the most volatile stocks — is Lixte Biotechnology Holdings, Inc. there?
Today Lixte Biotechnology Holdings, Inc. has the market capitalization of 3.67 M, it has decreased by −6.17% over the last week.
Yes, you can track Lixte Biotechnology Holdings, Inc. financials in yearly and quarterly reports right on TradingView.
LIXT net income for the last quarter is −986.03 K USD, while the quarter before that showed −1.01 M USD of net income which accounts for 2.46% change. Track more Lixte Biotechnology Holdings, Inc. financial stats to get the full picture.
No, LIXT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 24, 2024, the company has 4.00 employees. See our rating of the largest employees — is Lixte Biotechnology Holdings, Inc. on this list?
Like other stocks, LIXT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lixte Biotechnology Holdings, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lixte Biotechnology Holdings, Inc. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lixte Biotechnology Holdings, Inc. stock shows the sell signal. See more of Lixte Biotechnology Holdings, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.